Evidence map›Paper›PMID 35521177›Full record

ArticleRSC advances2019

Structural characterization and anti-inflammatory effect in hepatocytes of a galactoglucan from

Huiling Tang, Wenbing Nie, Jinna Xiao, Zhengqi Zha, Qiuli Chen, Hongping Yin

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Huiling TangSchool of Life Science and Technology, State Key Laboratory of Natural Medicines, China Pharmaceutical University No. 24 Tongjiaxiang Road Nanjing 210009 Jiangsu People's Republic of China yinhongping63@163.com +86 025 83271249 +86 025 83271108.
Wenbing NieSchool of Life Science and Technology, State Key Laboratory of Natural Medicines, China Pharmaceutical University No. 24 Tongjiaxiang Road Nanjing 210009 Jiangsu People's Republic of China yinhongping63@163.com +86 025 83271249 +86 025 83271108.
Jinna XiaoSchool of Life Science and Technology, State Key Laboratory of Natural Medicines, China Pharmaceutical University No. 24 Tongjiaxiang Road Nanjing 210009 Jiangsu People's Republic of China yinhongping63@163.com +86 025 83271249 +86 025 83271108.
Zhengqi ZhaSchool of Life Science and Technology, State Key Laboratory of Natural Medicines, China Pharmaceutical University No. 24 Tongjiaxiang Road Nanjing 210009 Jiangsu People's Republic of China yinhongping63@163.com +86 025 83271249 +86 025 83271108.
Qiuli ChenSchool of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210029 People's Republic of China.
Hongping YinSchool of Life Science and Technology, State Key Laboratory of Natural Medicines, China Pharmaceutical University No. 24 Tongjiaxiang Road Nanjing 210009 Jiangsu People's Republic of China yinhongping63@163.com +86 025 83271249 +86 025 83271108.ORCID https://orcid.org/0000-0002-5463-0150
China Pharmaceutical University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The galactoglucan ACP2 was isolated from cultured

Identifiers

PMID35521177
PMCPMC9061278
OpenAlexW2921352185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.